ClinicalTrials.gov
 Home    Search    Study Topics    Glossary  
 

  Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Study Evaluating IPI-504 in Patients With Gastrointestinal Stromal Tumors (GIST) Following Failure of at Least Imatinib and Sunitinib

This study is currently recruiting participants.
Study NCT00688766.   Last updated on December 2, 2008.   Information provided by Infinity Pharmaceuticals

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:
1 Conditions listed in this trial
Gastrointestinal Stromal Tumors
2 More general conditions related to this trial
Digestive System Diseases
Digestive System Neoplasms
Gastrointestinal Diseases
Gastrointestinal Neoplasms
Neoplasms
Neoplasms by Site
3 Interventions listed in this trial
placebo
4 Additional drug interventions recognized in this trial
Sunitinib
5 More general drug interventions related to this trial
Angiogenesis Inhibitors
Angiogenesis Modulating Agents
Antineoplastic Agents
Growth Inhibitors
Growth Substances
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
6 Sponsors listed in this trial
Infinity Pharmaceuticals
MedImmune LLC
AstraZeneca




Links to all studies - primarily for crawlers